摘要 |
The process allows a pasteurised preparation of blood clotting factor VIII, which is virtually free of immunoglobulins, isoagglutinins, fibronectin and coagulable fibrinogen, to be obtained. A preparation of this type can be used to treat disturbances of blood clotting. |